ResearcherUniversity of California, Los AngelesActive in the last 2 years
William H. Isacoff
Matched on OpenAlex author ID A5002646886. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 5
- Treatment of Elderly Patients with Advanced Pancreatic Ductal Adenocarcinoma Utilizing a Metronomic Dose and Schedule of Chemotherapy: A Better Approach Co-author DOI 10.20944/preprints202510.0364.v1↗
- ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers14122906↗
- Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retro… Co-author DOI 10.1007/s11523-018-0572-3↗
- Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival. Co-author DOI 10.1001/jamasurg.2013.2690↗
- Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. Co-author DOI 10.1245/s10434-013-3159-3↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Erlinda Maria Gordon · 1 shared paper, 2025 · strength 0.28
- Kenneth H. Yu · 1 shared paper, 2022 · strength 0.20
- Timothy R. Donahue · 3 shared papers, 2013–2018 · strength 0.16
- Paper Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients … DOI 10.1007/s11523-018-0572-3↗
- Paper Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and … DOI 10.1001/jamasurg.2013.2690↗
- Paper Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. DOI 10.1245/s10434-013-3159-3↗
- Howard A. Reber · 3 shared papers, 2013–2018 · strength 0.16
- Paper Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients … DOI 10.1007/s11523-018-0572-3↗
- Paper Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and … DOI 10.1001/jamasurg.2013.2690↗
- Paper Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. DOI 10.1245/s10434-013-3159-3↗
- Oscar Joe Hines · 3 shared papers, 2013–2018 · strength 0.16
- Paper Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients … DOI 10.1007/s11523-018-0572-3↗
- Paper Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and … DOI 10.1001/jamasurg.2013.2690↗
- Paper Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. DOI 10.1245/s10434-013-3159-3↗
- William Arthur Hoos · 1 shared paper, 2018 · strength 0.09
- Lola Rahib · 1 shared paper, 2018 · strength 0.09
- Graham W. Donald · 2 shared papers, 2013–2014 · strength 0.07
- Brian E. Kadera · 2 shared papers, 2013–2014 · strength 0.07
- Matthew M. Rochefort · 2 shared papers, 2013–2014 · strength 0.07
- James S. Tomlinson · 2 shared papers, 2013–2014 · strength 0.07
- David W. Dawson · 1 shared paper, 2014 · strength 0.04
- Zev A. Wainberg · 1 shared paper, 2013 · strength 0.03
- Jacob S. Ankeny · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.